NovoCure (NVCR) drew fresh attention after raising its 2026 net revenue outlook to US$736 million to US$743 million, paired with third quarter results that showed higher sales and a smaller net loss. ...
Source LinkNovoCure (NVCR) drew fresh attention after raising its 2026 net revenue outlook to US$736 million to US$743 million, paired with third quarter results that showed higher sales and a smaller net loss. ...
Source Link
Comments